Technical Strength Analyser Avaiable at Technical Analysis of Stocks    Interactive Charts Enhanced to include Financial & Technical Data in One View
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Wockhardt , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength

Charts Of Wockhardt Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

End Of Day Price282.15
Previous EOD Price284.15
Price Change -2.000
Change % -0.704%
Volume879.80 K
Five Day Avg Vol3497.41 K
Last Business Date21-Jan-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 26.50 10.37
Two Weeks 41.15 17.07
One Month 33.90 13.66
Three Months 15.70 5.89
Six Months -56.350 -16.647
One Year -212.550 -42.965

Highs / Lows

One Week297.9256.0
Two Weeks297.9237.1
One Month297.9232.0
Three Months312.0232.0
Six Months346.8230.15
One Year500.95230.15

Key Moving Average

5 Days 277.16276.377
15 Days 253.997261.146
20 Days 251.225258.15
50 Days 254.709257.698
100 Days 263.944273.197
200 Days 318.06320.221
Detailed MA Analysis of WOCKPHARMA ...

Key Technical Indicators

MACD 7.61
RSI 84.04
RSI (Smooth) 71.01
ADX 28.86
Chaikin Money Flow -0.186
Williams %R -24.648
PSAR 250.08
Detailed Tech Analysis WOCKPHARMA ...

Financial Data Highlights

Market Cap3125.49
Book Value/ Share229.135
Enterprise Value230.99
Revenue TTM3690.28
Gross Profit TTM2262.09
Revenue /Share TTM333.39
Consensus Target450.00
Key Financial Highlights WOCKPHARMA ...

Key Financial Ratios

Div Yield0.000
Trailing PE0.000
Forward PE0.000
Key Financial Ratios WOCKPHARMA ...

Key Profit & Loss Data

Net Inc -194.530 68.02 %
Ops Income-31.090 84.83 %
Revenue4158.38 5.96 %
Ops Expense4189.47 1.45 %
PBT-300.320 53.16 %
Gross Profit2262.09 9.27 %
Div Paid-0.020 80.00 %

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR8.953.17
Week PR18.856.68
Month PR65.9023.36
5 Day Period19.707.27
10 Day Period12.574.78
5 Week Period25.8510.52
3 Months Period46.1019.84
Price Range /Volatility WOCKPHARMA ...

Highlights & Chart Patterns of Wockhardt Ltd.

Share has hit One Month high on 20-Jan-20 (Yesterday).
Stock has jumped by more than 10% in last two weeks from its lowest level of 237.1 dt 08-Jan-20
Stock has jumped by more than 15% in last One Month from its lowest level of 232.0 dt 01-Jan-20.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Stock - Wockhardt Ltd. has gud price range with fall in vol market in uptrend
Stock - Wockhardt Ltd. has gud price range with fall in vol market in uptrend
As Per ADX, stock is in trend with ADX of 28.8639 and is trending for 2 Days
More Chart Patterns Wockhardt Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Wockhardt Ltd.

Date Open High Low Close Volume
21-Jan-20 285.00 288.00 279.05 282.15 879 K
20-Jan-20 288.00 297.90 280.15 284.15 2143 K
17-Jan-20 275.00 289.85 268.45 286.55 3872 K
16-Jan-20 265.00 295.70 265.00 273.65 9740 K
15-Jan-20 256.00 262.00 256.00 259.30 851 K
14-Jan-20 246.00 259.45 246.00 255.65 1909 K
13-Jan-20 246.70 248.45 244.35 246.20 308 K
10-Jan-20 245.00 251.50 243.30 245.55 792 K
09-Jan-20 245.00 245.55 243.00 244.20 369 K
08-Jan-20 237.10 243.85 237.10 240.60 518 K
About Wockhardt Limited
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients (APIs), formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, a r-DNA insulin; Wepox, a recombinant erythropoietin is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 2349, WCK 4873, and WCK 4086 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.